Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Phase II Study About Efficacy and Safety of the Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients With Refractory Cancer Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03362073

Organisation Name: Pusan National University Yangsan Hospital

Overal Status: Recruiting

Start Date: June 1, 2018

Last Update: August 25, 2020

Lead Sponsor: Pusan National University Yangsan Hospital

Brief Summary: To establish the role of ketamine in hospitalized terminally ill cancer patients with refractory cancer pain, using continuous intravenous infusion of ketamine

Conditions:
  • Ketamine
  • Refractory Cancer Pain


Total execution time in seconds: 0.15213513374329